Company profile
Adaptimmune Therapeutics plc (ADAP)
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
AD01 | Transaction MzUxMjU4MDM2MmFkaXF6a2N4
Published 25 Mar 2026 19:23
AD01 | Transaction MzUxMjU4MDE0OWFkaXF6a2N4
Published 25 Mar 2026 19:17
Last accounts made up date
Last confirmation statement made up date
SH01 | Transaction MzQ0NDk0NTk5OWFkaXF6a2N4
Published 26 Nov 2024 03:29
SH01 | Transaction MzQ0NDI3NzUyOWFkaXF6a2N4
Published 20 Nov 2024 12:31
SH01 | Transaction MzQzODQyMzYwOWFkaXF6a2N4
Published 04 Oct 2024 11:45
SH01 | Transaction MzQzODE2MTcxM2FkaXF6a2N4
Published 02 Oct 2024 03:51
SH01 | Transaction MzQzNzk5MDMzMmFkaXF6a2N4
Published 01 Oct 2024 04:49
SH01 | Transaction MzQzNDQ2NTY1OGFkaXF6a2N4
Published 04 Sep 2024 09:31
SH01 | Transaction MzQzMzQ5MTQ4NWFkaXF6a2N4
Published 27 Aug 2024 16:26
SH01 | Transaction MzQzMzA3OTgxNGFkaXF6a2N4
Published 22 Aug 2024 09:38
Company registered at Companies House
